British Blood Transfusion Society (BBTS) Annual Conference 2026 — Event Research & Buyer Fit Description

1) Event fundamentals (from official source)

• Event name: BBTS Annual Conference 2026
• Dates: 15–17 September 2026
• Venue: SEC Glasgow
• City / Country: Glasgow, United Kingdom
• What it is: A three-day conference focused on the needs of transfusion professionals, combining scientific/clinical sessions, peer collaboration, and networking via social events (including a Conference Dinner and Awards Ceremony).

2) Who attends (BUYERS / ATTENDEES)

BBTS Annual Conference is not structured like a consumer or general business expo. It is purpose-built for the transfusion and transfusion-adjacent laboratory ecosystem—meaning the “buyer” stakeholders we should target are typically the clinical and laboratory decision-makers who influence procurement, evaluation, purchasing approvals, clinical governance sign-off, and long-cycle technology adoption.

Primary attendee group (core): transfusion professionals

• Transfusion practitioners and transfusion service professionals
• Hospital laboratory professionals involved in transfusion testing and blood component workflows
• Laboratory managers and technical leads working with blood bank processes
• Clinical scientists and clinicians working in red cell services, serology, immunohematology, and patient blood management pathways
• Professionals responsible for donor services and donations processes (where transfusion services connect to donor operations and clinical outcomes)
• Early career professionals in transfusion medicine and laboratory medicine tracks

Secondary attendee group (influencers + implementers): programme, governance, and safety stakeholders

• Governance and quality leads aligned to patient safety and compliance
• Professionals focused on serious hazards of transfusion and haemovigilance learning
• Cybersecurity and operational resilience stakeholders in the context of blood bank technology (as indicated by the “Cyber Attack Lessons Learned” plenary topic)

Commercial-facing attendee group (exhibitor-led buyers): product and service decision makers

The event includes 25+ exhibitors demonstrating products and advising on services related to transfusion technology and products. The strongest “buyer” density typically clusters around exhibitors’ commercial and clinical support teams who attend to evaluate interest, run demonstrations, and convert engagement into trials, purchasing pathways, and institutional approvals.

3) Where the show is happening + attendee geographic origin

• Show location: SEC Glasgow (Glasgow, United Kingdom)
• Geographic origin (reliable from official text): the conference brings delegates “from around the globe.”
• Likely practical footprint: while the event is global in reach, the venue (Scotland/UK) implies a meaningful UK-centric and wider European participation base for transfusion service professionals and laboratory medicine teams.

For international buyer targeting, the most relevant approach is to focus on transfusion technology leaders and internationally operating med/diagnostics firms that support UK sites via regional clinical application teams, service teams, and distributor networks.

4) Audience reach (Local / National / Global)

Based on the official description, BBTS 2026 has a global audience reach:

• Local component: Glasgow/Scotland-area delegates and UK attendees who travel regionally
• National component: strong participation from across the UK transfusion and laboratory networks
• Global component: explicitly described as bringing delegates “from around the globe”

This mix matters for buyer lists: the most conversion-oriented profiles usually combine clinical transfusion/lab roles with procurement influence and vendor evaluation authority—often present among both domestic and international attendee cohorts.

5) Estimated attendance (expected total footfall)

The official page states the programme structure and exhibitor count (25+ exhibitors) and speaker volume (more than 80 speakers), but it does not provide an official total attendance number. Therefore, we only estimate attendance directionally:

• Expected pattern: a medium-to-large specialist medical conference with multiple concurrent streams (24 sessions) and heavy representation from transfusion/lab services
• Anchor indicators we can rely on:
  • 24 sessions
  • 80+ speakers
  • 25+ exhibitors

If we receive internal/previous-year attendance benchmarks (from the client product review or historical event reports), we can refine expected footfall with more precision. For now, the best “buyer fit” signal is the event’s density of transfusion-focused decision communities and exhibitor engagement volume rather than an unverified total number.

6) Job profiles, industries & event type

6.1 Event type

Event type: Specialist clinical and scientific conference with an exhibition component, focused on transfusion medicine, blood bank technology, cellular therapies, components processing, and transfusion safety.

6.2 Job profiles to target (BUYERS / buying-influencers)

• Transfusion Service / Blood Bank roles:
  • Transfusion Practitioner
  • Blood Bank Technologist / Blood Bank Specialist
  • Transfusion laboratory manager
  • Director of Transfusion Services
  • Immunohematology / Serology lead
• Clinical laboratory governance roles:
  • Clinical Scientist (Immunology / Haematology / Laboratory Medicine)
  • Laboratory Operations Manager
  • Quality & Compliance Manager (clinical / laboratory QA)
  • Haemovigilance / Safety & Risk lead
• Patient Blood Management (PBM) roles:
  • PBM Programme Lead
  • Clinical Lead, Patient Blood Management
  • Director, Transfusion Medicine & PBM
• Technology evaluation & implementation roles (often the highest commercial buyer fit):
  • Laboratory Informatics / Systems lead (including cybersecurity awareness)
  • Technical Specialist / Clinical Application Specialist (vendor side)
  • Procurement decision-makers aligned to laboratory equipment and consumables
• Exhibitor-side commercial roles (where conversion typically happens):
  • Clinical Affairs Manager
  • Business Development Manager (Blood Bank / Transfusion)
  • Regional Sales Manager (Transfusion / Laboratory Diagnostics)
  • Service Manager / Field Service Manager (installation, maintenance, upgrades)

6.3 Relevant industries (aligned to Apollo-style filtering themes, without naming any specific tool)

• Hospital & Health Care
• Hospitality (not a primary fit; typically irrelevant for this event’s buyer intent)
• Medical Practice
• Medical Devices
• Pharmaceuticals (adjacent; relevant when tied to transfusion-related therapies and clinical pathways)
• Biotechnology (adjacent; especially with “Cellular Therapies” sessions)
• Computer & Network Security (adjacent through “Cyber Attack Lessons Learned”)
• Health, Wellness & Fitness (generally adjacent at best; primary fit remains transfusion/lab/clinical)
• Events Services (only for vendor operations; not the buyer core)

7) Key focus areas & buyer engagement

The BBTS 2026 conference programme themes explicitly define the buyer relevance. Each theme indicates the kinds of vendors and service providers that should be targeted, and the types of decision-makers likely to be present.

7.1 Confirmed programme topics (from official description)

• Blood Bank Technology (SIG)
• Cellular Therapies (SIG)
• Components (SIG)
• Cyber Attack Lessons Learned (plenary)
• BBTS Awards Plenary
• Hospital Laboratory Session
• Microbiology (SIG)
• Equality, Diversity and Inclusion
• Paediatrics (SIG)
• Patient Blood Management
• Red Cell (SIG)
• Clinical Case Studies
• Serology Case Studies
• Genotyping
• Transfusion Practitioner Session
• Serious Hazards of Transfusion
• Early Career Professionals Session
• Donors and Donations Session
• Sustainability in Blood Transfusion

7.2 Buyer engagement angles that align to these themes

• Safety & risk reduction: “Serious Hazards of Transfusion” plus practical lab governance needs
• Quality improvements: case studies and clinical pathway learnings
• Technology modernization: “Blood Bank Technology,” automation-related service needs, and component processing improvements
• Transfusion testing excellence: serology, genotyping, and red cell pathways suggest demand for diagnostic platforms and systems
• Operational resilience: “Cyber Attack Lessons Learned” implies interest in secure lab informatics, validated IT infrastructure, and incident readiness
• Patient-focused outcomes: Patient Blood Management and paediatrics sessions suggest adoption of structured PBM protocols and evidence-based approaches
• Sustainability: sustainability in blood transfusion can create engagement for waste reduction, supply chain optimization, and resource efficiency services

8) Sample buyer company names (BUYERS ONLY) + websites

Below are representative buyer-style organizations likely to have relevance to transfusion technology, blood bank systems, diagnostics, cellular therapies support, and clinical lab services. These are intended as starter accounts for outreach and Apollo-style targeting (final selection should be refined after we review the client’s product category and ideal buyer requirements).

Important: the best buyers depend on the client product fit. Please share the client website so we can confirm the exact “buyer fit” (e.g., equipment vs consumables vs software vs services vs cybersecurity vs PBM programme support).

Priority	Company	Website	Best Title to Target	Why This is a Good Buyer Fit
1	Terumo Blood and Cell Technologies	https://www.terumobct.com	Regional Sales Manager (Blood & Cell Technologies) / Clinical Application Specialist	Strong fit for blood bank technology and components workflow solutions; likely to exhibit and run clinical demos aligned to transfusion practice.
2	Haemonetics	https://www.haemonetics.com	Business Development Manager (Transfusion / Blood Bank) / Clinical Affairs Manager	Relevant to component processing and transfusion systems; engagement is typically high where lab outcomes and safety matter.
3	Werfen	https://www.werfen.com	Sales Director (Immunoassay / Transfusion) / Regional Clinical Specialist	Direct relevance for serology and testing workflows; strong alignment with genotyping/serology case study interests.
4	CSL Behring	https://www.cslbehring.com	UK Clinical Partnerships Manager / Medical Affairs Lead (Heme)	Adjacency through transfusion medicine outcomes and clinical pathways; useful where products connect to patient blood management.
5	Octapharma	https://www.octapharma.com	Medical Science Liaison / UK Clinical Services Manager	Transfusion-adjacent therapies and clinical support; likely to align with serious hazards, paediatrics, and safety conversations.
6	Grifols	https://www.grifols.com	Director of Clinical Affairs (Transfusion) / Business Development Manager (Blood Products)	Strong transfusion-related portfolio and clinical engagement; fit for donors/donations and blood safety themes.
7	Fresenius Kabi	https://www.fresenius-kabi.com	UK Country Manager (Hospital / Medical) / Clinical Education & Partnerships Manager	Relevant where clinical therapies intersect with transfusion pathways and hospital laboratory decision-making.
8	Sartorius	https://www.sartorius.com	Sales Manager (Laboratory Systems) / Application Specialist	Good fit for laboratory technology and systems where quality and process controls are important.
9	Abbott	https://www.abbott.com	UK Regional Sales Manager (Diagnostics) / Clinical Applications Manager	Diagnostic relevance for serology and testing workflows; useful for genotyping and red cell pathways depending on product category.
10	Roche Diagnostics	https://diagnostics.roche.com	Clinical Marketing Manager / Regional Sales Lead (Diagnostics)	Serology/genotyping diagnostic ecosystems often map to transfusion lab testing interests; strong buyer likelihood.
11	Thermo Fisher Scientific	https://www.thermofisher.com	Commercial Manager (Clinical Diagnostics) / Service & Support Director	Broad lab solutions and services; aligns with hospital laboratory session plus technology and safety needs.
12	Danaher (Beckman Coulter)	https://www.beckmancoulter.com	UK Sales Lead (Laboratory Diagnostics) / Clinical Application Specialist	Strong alignment where transfusion labs interface with diagnostics and automation; buyer interest depends on specific workflows.
13	VWR / Avantor (distribution ecosystem)	https://www.avantorsciences.com	Category Manager (Clinical Lab Supplies) / Account Executive (NHS / Labs)	Often relevant for consumables, lab supplies, and service relationships in hospital laboratory networks.
14	Promedica (turns into broader lab services needs depending on offering)	https://www.example.com	Customer Success Lead (Lab Services) / Service Delivery Manager	Placeholder for buyer mapping after client product fit review. Use only if the client sells services or integration for transfusion labs.
14	LAB Informatics / Secure IT providers (category buyer)	https://www.example.com	Head of Cybersecurity Solutions (Healthcare) / Technical Account Manager	Aligned with the “Cyber Attack Lessons Learned” theme; ideal if the client product is cybersecurity, SOC, lab IT security, or resilience tools.
15	Abacus Next (for clinical lab analytics category, if applicable)	https://www.example.com	Business Development Manager (Healthcare Analytics) / Product Marketing Manager	Placeholder. Include only if the client sells analytics, reporting, transfusion safety monitoring, or lab workflow software.
16	Key distributor networks in the UK (blood bank / lab diagnostics distribution)	https://www.example.com	National Accounts Manager (Healthcare) / UK Sales Director	Placeholder. Distributors can be high-value buyers if the client product is routed through UK accounts.
17	Technological service vendors for medical devices	https://www.example.com	Service Operations Manager (Medical Devices) / Installation & Validation Lead	Placeholder. If the client provides maintenance, calibration, validation, or device lifecycle services, service managers are often the right buyers.
18	Specialist haemovigilance & safety solution providers (category buyer)	https://www.example.com	Director of Clinical Safety Solutions / Product Owner (Patient Safety)	Aligned with “Serious Hazards of Transfusion” and safety learning; best if the client offers safety event tracking, reporting, or compliance tooling.

Top 5 starter accounts (most broadly relevant to transfusion technology and testing): Terumo Blood and Cell Technologies, Haemonetics, Werfen, Grifols, Octapharma.

Note about the placeholders: for buyer lists to be accurate and usable, we should remove placeholder entries and replace them with real company names based on the client’s product category. Once the client website is shared, we will map to the closest transfusion conference-aligned industries and correct buyer titles.

9) Client-product fit check (required to finalize “best buyers”)

We can only recommend the best buyer segments confidently after we review the client’s product category, because BBTS attracts multiple buyer types:

• If the client sells blood bank / lab equipment or consumables: target clinical application and regional sales plus lab technology decision influencers.
• If the client sells diagnostics or testing platforms: target serology/genotyping workflow decision-makers and clinical application leads.
• If the client sells software / informatics: target lab informatics leads and cybersecurity-adjacent decision profiles.
• If the client sells PBM-related programmes or clinical education: target PBM leads and clinical pathway management roles.
• If the client sells safety/haemovigilance solutions: target governance, patient safety, and incident reporting leaders.

Please share the client website so we can review it and confirm:
1) which BBTS 2026 themes it maps to,
2) which job titles become the highest-conversion buyers,
3) which company types should be prioritized and which should be deprioritized.

10) Summary recommendation (buyer-fit positioning)

BBTS Annual Conference 2026 is highly relevant for buyer outreach because it is a transfusion-focused, clinical-lab oriented event with:

• Global delegate positioning (“around the globe”)
• 24 sessions covering core transfusion pathways (red cells, serology, genotyping, patient blood management, cellular therapies, components)
• 80+ speakers reflecting specialist depth
• 25+ exhibitors demonstrating transfusion technology and services—strong buyer presence
• Modern concerns like cybersecurity and sustainability explicitly included

After we review the client’s website, we will refine the buyer company list to remove irrelevant categories, correct job title targeting, and produce a tighter “best buyers first” set designed for maximum relevance to the BBTS 2026 audience themes.